Optifolin+ improved blood measures in 24 healthy adults, but better health effects remain unproven. Nutritional Outlook reported on Balchem’s claims for its branded ingredient, Optifolin+. A study compared it with Folic Acid. The same people tried both forms at different times. Optifolin+ reached its highest blood levels faster. It also produced higher Folate status measures. The supplied report did not give the size of those differences. The key gap concerns methylation, a process where cells transfer tiny chemical groups. Balchem’s messaging suggests its ingredient may support this process better. But the human study did not measure it. At the time of the article, no human trial testing that claim had been published. Balchem also cited 98% methyl capacity and a sevenfold methyl agent advantage. These figures describe claimed chemical-transfer potential, not measured health gains. They were calculated internally, rather than shown as benefits in people. Tests in cells suggested a possible way the ingredient could work. They did not confirm the same effects in the human body. For this community, the useful distinction is between blood results and broader promises. A higher blood measure does not, by itself, prove better health. When comparing your own results, details can make community notes more useful. These include the product, amount taken, test dates, and other routine changes. Keeping those details beside uploaded bloodwork helps separate what changed from what remains unknown. Personal trends can support discussion without settling claims this study never tested. What changes, if any, have you seen in your bloodwork while using different forms of this vitamin?